CoinInsight360.com logo CoinInsight360.com logo
America's Social Casino

crypto.news 2025-06-10 07:31:49

Staked Injective ETF in sight as Canary Capital registers Delaware trust

Canary Capital has registered a Delaware trust for a staked Injective ETF, marking an early step toward potentially launching a tradable INJ product in the U.S. Canary Capital has established a trust for an exchange-traded fund offering exposure to staked Injective ( INJ ). The trust, named “Canary Staked INJ ETF,” was registered with the Delaware Division of Corporations and is designed to provide staking-based returns linked to the Injective blockchain. While this filing does not guarantee the fund will launch, it follows the common path taken by many crypto ETF issuers. A similar INJ product already exists in Europe, where asset manager 21Shares offers an Injective ETP that captures staking yield. You might also like: Sui faces further sell-off risk as SEC delays Canary Capital’s spot SUI ETF decision This move follows the firm’s earlier filing for a Staked Cronos ( CRO ) ETF in May, which aims to offer investors access to Cronos tokens and associated staking yields. The company is also awaiting a decision from the U.S. Securities and Exchange Commission on its proposed spot Sui ( SUI ) ETF, following a delayed response from the regulator earlier this month. Additionally, Canary Capital recently registered a Delaware trust for a Staked Sei ( SEI ) ETF, marking an initial step toward launching a product that would offer investors exposure to SEI token staking rewards. Just days earlier, the firm submitted a Form S-1 for a Staked Tron ( TRX ) ETF, outlining similar staking mechanics. Beyond these, Canary has also filed proposals for ETFs tied to Solana ( SOL ), Axelar ( AXL ), and Ripple ( XRP ), and has submitted a unique filing for an ETF tracking the Pudgy Penguins ( PENGU ) ecosystem—combining exposure to the PENGU governance token and associated NFTs. You might also like: Canary Capital registers Delaware trust for staked Sei ETF

Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.